Literature DB >> 24428402

Rapid identification of Enterobacter hormaechei and Enterobacter cloacae genetic cluster III.

S Ohad1, C Block, V Kravitz, A Farber, S Pilo, R Breuer, E Rorman.   

Abstract

AIM: Enterobacter cloacae complex bacteria are of both clinical and environmental importance. Phenotypic methods are unable to distinguish between some of the species in this complex, which often renders their identification incomplete. The goal of this study was to develop molecular assays to identify Enterobacter hormaechei and Ent. cloacae genetic cluster III which are relatively frequently encountered in clinical material. METHODS AND
RESULTS: The molecular assays developed in this study are qPCR technology based and served to identify both Ent. hormaechei and Ent. cloacae genetic cluster III. qPCR results were compared to hsp60 sequence analysis. Most clinical isolates were assigned to Ent. hormaechei subsp. steigerwaltii and Ent. cloacae genetic cluster III. The latter was proportionately more frequently isolated from bloodstream infections than from other material (P < 0·05).
CONCLUSION: The qPCR assays detecting Ent. hormaechei and Ent. cloacae genetic cluster III demonstrated high sensitivity and specificity. SIGNIFICANCE AND IMPACT OF THE STUDY: The presented qPCR assays allow accurate and rapid identification of clinical isolates of the Ent. cloacae complex. The improved identifications obtained can specifically assist analysis of Ent. hormaechei and Ent. cloacae genetic cluster III in nosocomial outbreaks and can promote rapid environmental monitoring. An association was observed between Ent. cloacae cluster III and systemic infection that deserves further attention.
© 2014 The Society for Applied Microbiology.

Entities:  

Keywords:  PCR; identification; molecular genetic

Mesh:

Substances:

Year:  2014        PMID: 24428402     DOI: 10.1111/jam.12439

Source DB:  PubMed          Journal:  J Appl Microbiol        ISSN: 1364-5072            Impact factor:   3.772


  7 in total

1.  Genomic epidemiology of global VIM-producing Enterobacteriaceae.

Authors:  Yasufumi Matsumura; Gisele Peirano; Rebekah Devinney; Patricia A Bradford; Mary R Motyl; Mark D Adams; Liang Chen; Barry Kreiswirth; Johann D D Pitout
Journal:  J Antimicrob Chemother       Date:  2017-08-01       Impact factor: 5.790

2.  Global Molecular Epidemiology of IMP-Producing Enterobacteriaceae.

Authors:  Yasufumi Matsumura; Gisele Peirano; Mary R Motyl; Mark D Adams; Liang Chen; Barry Kreiswirth; Rebekah DeVinney; Johann D D Pitout
Journal:  Antimicrob Agents Chemother       Date:  2017-03-24       Impact factor: 5.191

Review 3.  Nonribosomal peptide synthetase biosynthetic clusters of ESKAPE pathogens.

Authors:  Andrew M Gulick
Journal:  Nat Prod Rep       Date:  2017-08-02       Impact factor: 13.423

4.  Characteristics of Carbapenemase-Producing Enterobacteriaceae in Wastewater Revealed by Genomic Analysis.

Authors:  Ryota Gomi; Tomonari Matsuda; Masaki Yamamoto; Pei-Hsin Chou; Michio Tanaka; Satoshi Ichiyama; Minoru Yoneda; Yasufumi Matsumura
Journal:  Antimicrob Agents Chemother       Date:  2018-04-26       Impact factor: 5.191

5.  Enterobacter hormaechei subsp. hoffmannii subsp. nov., Enterobacter hormaechei subsp. xiangfangensis comb. nov., Enterobacter roggenkampii sp. nov., and Enterobacter muelleri is a later heterotypic synonym of Enterobacter asburiae based on computational analysis of sequenced Enterobacter genomes.

Authors:  Granger G Sutton; Lauren M Brinkac; Thomas H Clarke; Derrick E Fouts
Journal:  F1000Res       Date:  2018-05-01

6.  Development of a One-Step Multiplex PCR Assay for Differential Detection of Four species (Enterobacter cloacae, Enterobacter hormaechei, Enterobacter roggenkampii, and Enterobacter kobei) Belonging to Enterobacter cloacae Complex With Clinical Significance.

Authors:  Yang Ji; Peihong Wang; Tingting Xu; Yanzi Zhou; Rongchang Chen; Huaiqiu Zhu; Kai Zhou
Journal:  Front Cell Infect Microbiol       Date:  2021-05-18       Impact factor: 5.293

7.  Carbapenem-Resistant Enterobacter hormaechei ST1103 with IMP-26 Carbapenemase and ESBL Gene bla SHV-178.

Authors:  Jian-Jun Gou; Na Liu; Li-Hua Guo; Hao Xu; Tao Lv; Xiao Yu; Yun-Bo Chen; Xiao-Bing Guo; Yu-Ting Rao; Bei-Wen Zheng
Journal:  Infect Drug Resist       Date:  2020-02-20       Impact factor: 4.003

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.